In vivo imaging of early signs of dopaminergic neuronal death in an animal model of Parkinson's disease

Nicoletta Rizzi, Electra Brunialti, Silvia Cerri, Greta Cermisoni, Giovanna Levandis, Nicoletta Cesari, Adriana Maggi, Fabio Blandini, Paolo Ciana

Research output: Contribution to journalArticle

Abstract

The Parkinson's disease (PD) evolves over an extended period of time with the onset occurring long before clinical signs begin to manifest. Characterization of the molecular events underlying the PD onset is instrumental for the development of diagnostic markers and preventive treatments, progress in this field is hindered by technical limitations. We applied an imaging approach to demonstrate the activation of Nrf2 transcription factor as a hallmark of neurodegeneration in neurotoxin-driven models of PD. In dopaminergic SK-N-BE neuroblastoma cells, Nrf2 activation was detected in cells committed to die as proven by time lapse microscopy; in the substantia nigra pars compacta area of the mouse brain, the Nrf2 activation preceded dopaminergic neurodegeneration as demonstrated by in vivo and ex vivo optical imaging, a finding confirmed by co-localization experiments carried out by immunohistochemistry. Collectively, our results identify the Nrf2 signaling as an early marker of neurodegeneration, anticipating dopaminergic neurodegeneration and motor deficits.

Original languageEnglish
Pages (from-to)74-84
Number of pages11
JournalNeurobiology of Disease
Volume114
DOIs
Publication statusPublished - Jun 2018

Fingerprint

Parkinson Disease
Animal Models
Optical Imaging
Neurotoxins
Neuroblastoma
Microscopy
Transcription Factors
Immunohistochemistry
Brain
Therapeutics
Pars Compacta

Cite this

In vivo imaging of early signs of dopaminergic neuronal death in an animal model of Parkinson's disease. / Rizzi, Nicoletta; Brunialti, Electra; Cerri, Silvia; Cermisoni, Greta; Levandis, Giovanna; Cesari, Nicoletta; Maggi, Adriana; Blandini, Fabio; Ciana, Paolo.

In: Neurobiology of Disease, Vol. 114, 06.2018, p. 74-84.

Research output: Contribution to journalArticle

Rizzi, Nicoletta ; Brunialti, Electra ; Cerri, Silvia ; Cermisoni, Greta ; Levandis, Giovanna ; Cesari, Nicoletta ; Maggi, Adriana ; Blandini, Fabio ; Ciana, Paolo. / In vivo imaging of early signs of dopaminergic neuronal death in an animal model of Parkinson's disease. In: Neurobiology of Disease. 2018 ; Vol. 114. pp. 74-84.
@article{925cde087bdd4896b7a695aaf112f521,
title = "In vivo imaging of early signs of dopaminergic neuronal death in an animal model of Parkinson's disease",
abstract = "The Parkinson's disease (PD) evolves over an extended period of time with the onset occurring long before clinical signs begin to manifest. Characterization of the molecular events underlying the PD onset is instrumental for the development of diagnostic markers and preventive treatments, progress in this field is hindered by technical limitations. We applied an imaging approach to demonstrate the activation of Nrf2 transcription factor as a hallmark of neurodegeneration in neurotoxin-driven models of PD. In dopaminergic SK-N-BE neuroblastoma cells, Nrf2 activation was detected in cells committed to die as proven by time lapse microscopy; in the substantia nigra pars compacta area of the mouse brain, the Nrf2 activation preceded dopaminergic neurodegeneration as demonstrated by in vivo and ex vivo optical imaging, a finding confirmed by co-localization experiments carried out by immunohistochemistry. Collectively, our results identify the Nrf2 signaling as an early marker of neurodegeneration, anticipating dopaminergic neurodegeneration and motor deficits.",
author = "Nicoletta Rizzi and Electra Brunialti and Silvia Cerri and Greta Cermisoni and Giovanna Levandis and Nicoletta Cesari and Adriana Maggi and Fabio Blandini and Paolo Ciana",
note = "Copyright {\circledC} 2018 Elsevier Inc. All rights reserved.",
year = "2018",
month = "6",
doi = "10.1016/j.nbd.2018.02.005",
language = "English",
volume = "114",
pages = "74--84",
journal = "Neurobiology of Disease",
issn = "0969-9961",
publisher = "Academic Press Inc.",

}

TY - JOUR

T1 - In vivo imaging of early signs of dopaminergic neuronal death in an animal model of Parkinson's disease

AU - Rizzi, Nicoletta

AU - Brunialti, Electra

AU - Cerri, Silvia

AU - Cermisoni, Greta

AU - Levandis, Giovanna

AU - Cesari, Nicoletta

AU - Maggi, Adriana

AU - Blandini, Fabio

AU - Ciana, Paolo

N1 - Copyright © 2018 Elsevier Inc. All rights reserved.

PY - 2018/6

Y1 - 2018/6

N2 - The Parkinson's disease (PD) evolves over an extended period of time with the onset occurring long before clinical signs begin to manifest. Characterization of the molecular events underlying the PD onset is instrumental for the development of diagnostic markers and preventive treatments, progress in this field is hindered by technical limitations. We applied an imaging approach to demonstrate the activation of Nrf2 transcription factor as a hallmark of neurodegeneration in neurotoxin-driven models of PD. In dopaminergic SK-N-BE neuroblastoma cells, Nrf2 activation was detected in cells committed to die as proven by time lapse microscopy; in the substantia nigra pars compacta area of the mouse brain, the Nrf2 activation preceded dopaminergic neurodegeneration as demonstrated by in vivo and ex vivo optical imaging, a finding confirmed by co-localization experiments carried out by immunohistochemistry. Collectively, our results identify the Nrf2 signaling as an early marker of neurodegeneration, anticipating dopaminergic neurodegeneration and motor deficits.

AB - The Parkinson's disease (PD) evolves over an extended period of time with the onset occurring long before clinical signs begin to manifest. Characterization of the molecular events underlying the PD onset is instrumental for the development of diagnostic markers and preventive treatments, progress in this field is hindered by technical limitations. We applied an imaging approach to demonstrate the activation of Nrf2 transcription factor as a hallmark of neurodegeneration in neurotoxin-driven models of PD. In dopaminergic SK-N-BE neuroblastoma cells, Nrf2 activation was detected in cells committed to die as proven by time lapse microscopy; in the substantia nigra pars compacta area of the mouse brain, the Nrf2 activation preceded dopaminergic neurodegeneration as demonstrated by in vivo and ex vivo optical imaging, a finding confirmed by co-localization experiments carried out by immunohistochemistry. Collectively, our results identify the Nrf2 signaling as an early marker of neurodegeneration, anticipating dopaminergic neurodegeneration and motor deficits.

U2 - 10.1016/j.nbd.2018.02.005

DO - 10.1016/j.nbd.2018.02.005

M3 - Article

C2 - 29486298

VL - 114

SP - 74

EP - 84

JO - Neurobiology of Disease

JF - Neurobiology of Disease

SN - 0969-9961

ER -